Post by
Lesalpes29 on Jun 26, 2022 5:46pm
Big pharmas are watching us closely!
Fir sure : https://www.fiercebiotech.com/biotech/ma-down-big-pharma-likely-line-multiple-shots-goal-heading-2nd-half
Comment by
ScienceFirst on Jun 27, 2022 8:17am
There were some interesting deals in the half, particularly Pfizer’s $11.6 billion check for a chunk of Biohaven Pharmaceuticals. The New York Big Pharma carved out Biohaven’s migraine franchise while leaving some earlier-stage assets under the biotech’s purview.
Comment by
Legit62 on Jun 27, 2022 8:33am
SF, if we get good news on Vaccine front, it will really add to our value, besides the fact that we destroy tumors, safely, cost efficient, and minimal treatments compared to rivals
Comment by
Eoganacht on Jun 27, 2022 10:02am
Theralase's treatment destroys tumours completely, and that safely...how many anti-cancer drugs only shrink tumours at best? TLD1433 pdt should be a useful addition to most anti-cancer regimens to get the situation under control. What is a treatment like that worth? Should we just add up the cancer indications it's good for and multiply by a few billion?